pegylated interferon alpha 2b (NAL Pharma)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namepegylated interferon alpha 2b (NAL Pharma)
Drug Alias NameNAL-3756
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsMelanomaHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNal Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNal Pharma
Active IndicationsN/A
Inactive IndicationsMelanomaHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A